TNT esophagus

What is the Purpose of this Study?

For this type of cancer, standard treatment includes radiation therapy along with chemotherapy medicines such as carboplatin and paclitaxel. In this study, people will also receive extra chemotherapy for up to six months after the standard treatment is finished. This extra treatment is called consolidation chemotherapy. It uses common cancer medicines such as fluorouracil, leucovorin, oxaliplatin, and docetaxel. Some people may also receive a medicine called durvalumab, which helps the immune system fight cancer.

What is the Condition Being Studied?

Cancer of the esophagus

Who Can Participate in the Study?

This study is for adults who have a newly diagnosed cancer in the food pipe or where the food pipe meets the stomach. The cancer must be confirmed by lab testing and be at a certain stage that has not spread too far. People in the study will need to receive treatment with both radiation and chemotherapy. They must also have kidneys, liver, and blood that are working well enough to safely take part in the study.

Age Group
Adults

What is Involved?

The purpose of this study is to determine if adding additional chemotherapy, called consolidation chemotherapy, to the standard treatment can improve the tumor response.

Study Details

Full Title
A single-arm study of upfront chemotherapy with radiation therapy (CRT) followed by chemotherapy in localized esophageal adenocarcinoma
Principal Investigator
Associate Professor of Radiation Oncology
Protocol Number
IRB: PRO00120182
NCT: NCT07603375
Phase
Phase N/A
ClinicalTrials.gov
Status
INSTITUTIONAL APPROVAL SIGNOFF